Recently published article on generating endothelial and vascular smooth muscle cells from PBMC and urine-derived iPSCs November 4th, 2024, Vienna, AustriaA recent
Partnering with AIM Biotech November 4th, 2024, Vienna, Austria We are thrilled to announce that we have partnered with Singapore-based AIM
Newly published article on affinity-based purification of recombinant EVs October 18th, 2024, Vienna, AustriaA recent collaborative work has been published showcasing the
We participated to the ASEV and CzeSEV 2024 meeting in Vienna, Austria September 26th, 2024, Vienna, Austria We participated to the
New review published by LifeSaver Project Consortium September 5th, 2024, Vienna, Austria The LifeSaver Project Consortium has published a comprehensive review
Partnering with Chameleon Science August 19th, 2024, Vienna, Austria We are thrilled to announce that we have partnered with the new
Newly released telomerized amniotic epithelial cells August 13th, 2024, Vienna, Austria We are thrilled to announce the newest addition to our
Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024 June 27th, 2024, Vienna, Austria We participated as technology spotlight speakers at
Recent publication showcasing our ASC/TERT1 cells as EV production system May 23rd, 2024, Vienna, AustriaOur telomerized human adipose derived MSC (ASC/TERT1, also known in
Evercyte proudly introduces the EVscale™ platform April 29th, 2024, Vienna, Austria The collaborative effort of Evercyte, Phoenestra, and TAmiRNA has yielded the EVscale™ platform,
